A Phase 3, double-blind, placebo-controlled trial of SAGE-217 in postpartum depression: Assessment of depressive symptoms across multiple measures

Junker, H

PHARMACOPSYCHIATRY, 2020; 53 (2): 94

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索